Presentation is loading. Please wait.

Presentation is loading. Please wait.

Stage IV non–small cell lung cancer (NSCLC)

Published byCharlene Garrett Modified over 6 years ago

Similar presentations

Presentation on theme: "Stage IV non–small cell lung cancer (NSCLC)"— Presentation transcript:

1 Stage IV non–small cell lung cancer (NSCLC)
Stage IV non–small cell lung cancer (NSCLC). Upon evaluation for back pain, this patient was found to have a pleural effusion (A, B), and biopsy revealed NSCLC. Positron emission tomography/computed tomography (C) revealed a 5.4- by 3.6-cm hypermetabolic mass in the right middle lobe, many small satellite fluorodeoxyglucose (FDG)-avid right lung nodules, and extensive FDG-avid pleural-based masses on the right (T4N0M1). No disease was found outside the chest. Source: Non–Small Cell Lung Cancer, The MD Anderson Manual of Medical Oncology, 3e Citation: Kantarjian HM, Wolff RA. The MD Anderson Manual of Medical Oncology, 3e; 2016 Available at: Accessed: October 21, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved

Download ppt "Stage IV non–small cell lung cancer (NSCLC)"

Similar presentations

(A–C) Forms of non-small-cell carcinoma

(A–C) Forms of non-small-cell carcinoma
Brief pain inventory. (Reproduced with permission from the University of Texas MD Anderson Cancer Center, Department of Symptom Research, Houston, TX.

Brief pain inventory. (Reproduced with permission from the University of Texas MD Anderson Cancer Center, Department of Symptom Research, Houston, TX.
Miliary tuberculosis. (A) Frontal chest radiograph demonstrates innumerable tiny nodules distributed throughout both lungs. There is a hazy opacity at.

Miliary tuberculosis. (A) Frontal chest radiograph demonstrates innumerable tiny nodules distributed throughout both lungs. There is a hazy opacity at.
CT and PET imaging in non-small cell lung cancer

CT and PET imaging in non-small cell lung cancer
Long Survival of a Small-Cell Lung Cancer Patient Who Received Maintenance Chemotherapy with Irinotecan Case Rep Oncol 2013;6:569-573 - DOI:10.1159/000356826.

Long Survival of a Small-Cell Lung Cancer Patient Who Received Maintenance Chemotherapy with Irinotecan Case Rep Oncol 2013;6: DOI: /
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer  Haa-Na Song, MD,

Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer  Haa-Na Song, MD,
Same patient as in Fig. 44-3. The computed tomography positron emission tomography scan after four courses of hyperfractionated cyclophosphamide, vincristine,

Same patient as in Fig The computed tomography positron emission tomography scan after four courses of hyperfractionated cyclophosphamide, vincristine,
A. Schema of NSABP B-27 trial comparing neoadjuvant AC to neoadjuvant AC followed by neoadjuvant docetaxel and to neoadjuvant AC followed by adjuvant docetaxel.

A. Schema of NSABP B-27 trial comparing neoadjuvant AC to neoadjuvant AC followed by neoadjuvant docetaxel and to neoadjuvant AC followed by adjuvant docetaxel.
Schema of the NSABP B-34 trial evaluating adjuvant oral clodronate in patients with resected stage I and II operable breast cancer (Chemo, adjuvant chemotherapy;

Schema of the NSABP B-34 trial evaluating adjuvant oral clodronate in patients with resected stage I and II operable breast cancer (Chemo, adjuvant chemotherapy;
Large cell undifferentiated carcinoma of lung

Large cell undifferentiated carcinoma of lung
CT scan of the chest. These axial images of the lower chest demonstrate the difference in lung and soft tissue windows. This patient has a history of congenital.

CT scan of the chest. These axial images of the lower chest demonstrate the difference in lung and soft tissue windows. This patient has a history of congenital.
Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 
Evaluation of 18F-FDG PET-CT for Differentiation of Pulmonary Pathology in an Approach of Outpatient Fast Track Assessment  Tjeerd S. Aukema, MD, Renato.

Evaluation of 18F-FDG PET-CT for Differentiation of Pulmonary Pathology in an Approach of Outpatient Fast Track Assessment  Tjeerd S. Aukema, MD, Renato.
Angiosarcoma. (A) The dermis has been largely replaced by highly atypical cells in this patient with angiosarcoma. (B) Malignant cells form bizarre vascular.

Angiosarcoma. (A) The dermis has been largely replaced by highly atypical cells in this patient with angiosarcoma. (B) Malignant cells form bizarre vascular.
Squamous cell carcinoma

Squamous cell carcinoma
Eosinophilic pneumonia

Eosinophilic pneumonia
Incidental significant finding on FDG-PET/CT

Incidental significant finding on FDG-PET/CT
Nodular lymphocyte-predominant Hodgkin lymphoma. A

Nodular lymphocyte-predominant Hodgkin lymphoma. A
Advanced stage non–small cell lung cancer treatment algorithm

Advanced stage non–small cell lung cancer treatment algorithm
Algorithm for the classification of adult-onset primary myelodysplastic syndromes (MDS). This classification system is based on the 2008 criteria of the.

Algorithm for the classification of adult-onset primary myelodysplastic syndromes (MDS). This classification system is based on the 2008 criteria of the.

Similar presentations

Ads by Google